Novo Nordisk’s higher-dose Wegovy wins US approval, showing over 20% weight loss

FDA clears 7.2 mg version of blockbuster obesity drug as demand for weight-loss treatments continues to surge globally The post Novo Nordisk’s higher-dose Wegovy wins US approval, showing over 20% weight loss appeared first on Arabian Business: Latest News on the Middle East, Real Estate, Finance, and More .

Go to News Site